CVS saw a smaller jump after the report, paring some of its losses from earlier in the trading session.
CNBC reported that CVS proposed buying Aetna for $US200 per share.
This story is developing, check back here for more…
Business Insider Emails & Alerts
Site highlights each day to your inbox.